These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 2993665)

  • 21. Neutralization epitope of the varicella-zoster virus gH:gL glycoprotein complex.
    Forghani B; Ni L; Grose C
    Virology; 1994 Mar; 199(2):458-62. PubMed ID: 7510086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological studies on the antigenic relationship between herpes simplex virus and varicella-zoster virus.
    Wolff MH; Büchel F; Zoll A
    Immunobiology; 1979 Aug; 156(1-2):76-82. PubMed ID: 232073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type-specific identification of herpes simplex and varicella-zoster virus antigen in autopsy tissues.
    Martin JR; Holt RK; Langston C; Gilden DH; Richardson EP; Manz HJ; Singer DB
    Hum Pathol; 1991 Jan; 22(1):75-80. PubMed ID: 1845866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions.
    Para MF; Parish ML; Noble AG; Spear PG
    J Virol; 1985 Aug; 55(2):483-8. PubMed ID: 2991571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies.
    Keller PM; Lonergan K; Neff BJ; Morton DA; Ellis RW
    J Virol Methods; 1986 Sep; 14(2):177-88. PubMed ID: 3021804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive hemagglutination assays for the detection of antibodies to herpes viruses.
    Kino Y; Minamishima Y
    Microbiol Immunol; 1993; 37(5):365-8. PubMed ID: 8394981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topological distribution of virus-specific and cross-reactive antigenic determinants on the gB glycoprotein of the herpes simplex viruses.
    Eberle R; Courtney RJ
    J Med Virol; 1989 Apr; 27(4):309-16. PubMed ID: 2470853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
    Giller RH; Winistorfer S; Grose C
    J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antigenic and protein sequence homology between VP13/14, a herpes simplex virus type 1 tegument protein, and gp10, a glycoprotein of equine herpesvirus 1 and 4.
    Whittaker GR; Riggio MP; Halliburton IW; Killington RA; Allen GP; Meredith DM
    J Virol; 1991 May; 65(5):2320-6. PubMed ID: 1850013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of neutralizing antibody and T-cell responses to varicella-zoster virus (VZV) using Ty-virus-like particles carrying fragments of glycoprotein E (gE).
    Garcia-Valcarcel M; Fowler WJ; Harper DR; Jeffries DJ; Layton GT
    Vaccine; 1997; 15(6-7):709-19. PubMed ID: 9178473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
    Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
    Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A site of varicella-zoster virus vulnerability identified by structural studies of neutralizing antibodies bound to the glycoprotein complex gHgL.
    Xing Y; Oliver SL; Nguyen T; Ciferri C; Nandi A; Hickman J; Giovani C; Yang E; Palladino G; Grose C; Uematsu Y; Lilja AE; Arvin AM; Carfí A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6056-61. PubMed ID: 25918416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human monoclonal antibody against varicella-zoster virus glycoprotein III.
    Sugano T; Tomiyama T; Matsumoto Y; Sasaki S; Kimura T; Forghani B; Masuho Y
    J Gen Virol; 1991 Sep; 72 ( Pt 9)():2065-73. PubMed ID: 1654371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of monoclonal antibodies on limited proteolysis of native glycoprotein gD of herpes simplex virus type 1.
    Eisenberg RJ; Long D; Pereira L; Hampar B; Zweig M; Cohen GH
    J Virol; 1982 Feb; 41(2):478-88. PubMed ID: 6176725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Varicella-zoster virus gpI and herpes simplex virus gE: phosphorylation and Fc binding.
    Edson CM; Hosler BA; Waters DJ
    Virology; 1987 Dec; 161(2):599-602. PubMed ID: 2825425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Existence of similar antigenic-sites on varicella-zoster virus gpI and gpIV.
    Vafai A; Jensen K; Kubo R
    Virus Res; 1989 Aug; 13(4):319-36. PubMed ID: 2479191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a varicella-zoster virus neutralization assay using a glycoprotein K antibody enzyme-linked immunosorbent spot assay.
    Chen L; Liu J; Wang W; Ye J; Wen L; Zhao Q; Zhu H; Cheng T; Xia N
    J Virol Methods; 2014 May; 200():10-4. PubMed ID: 24486923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
    Mester JC; Highlander SL; Osmand AP; Glorioso JC; Rouse BT
    J Virol; 1990 Nov; 64(11):5277-83. PubMed ID: 1698994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
    Schmidt NJ; Gallo D
    J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.